Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma 39Dendritic Cell Sarcoma, Interdigitating 30Lymphoma 22Burkitt Lymphoma 22Lymphoma, Large B-Cell, Diffuse 20Osteosarcoma 17Neuroectodermal Tumors, Primitive, Peripheral 17Lymphoma, Non-Hodgkin 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia 15Lymphoma, Large-Cell, Immunoblastic 14Lymphoma, Mantle-Cell 12Lymphoma, Follicular 12Leukemia, Myeloid, Acute 12Leukemia, Lymphocytic, Chronic, B-Cell 12Rhabdomyosarcoma 11Lymphoma, B-Cell, Marginal Zone 11Sarcoma, Ewing 10Recurrence 10Neuroblastoma 10Blast Crisis 10Leukemia, Myeloid, Accelerated Phase 9Central Nervous System Neoplasms 9Neoplasms, Plasma Cell 8Myelodysplastic Syndromes 8Multiple Myeloma 8Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 8Brain Neoplasms 8Myeloproliferative Disorders 7

Interventions

pevonedistat 1Vincristine 1Rituximab 1Prednisone 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acromesomelic dysplasia, Maroteaux type × Etoposide × Sarcoma × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡